Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Collins

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Cureus|July 26, 2024
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation PlanningLauren Ching, Matthew Bourne, Tim Kearney, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2020
Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomyStephanie Yoon, Minsong Cao, Nima Aghdam, et al.
Scientific Reports|July 28, 2019
Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERNBen Webster, Peter Ivanov, Ben Russell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2020
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI ResistanceRima K Acosta, Madeleine Willkom, Kristen Andreatta, et al.
Radiation Oncology (London, England)|November 16, 2014
Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3))Einsley Janowski, Leonard N Chen, Joy S Kim, et al.
BMJ Open|October 19, 2021
Buteyko method for people with asthma: a protocol for a systematic review and meta-analysisKarla Morganna Pereira Pinto de Mendonça, Sean Collins, Tácito Zm Santos, et al.
World Journal of Urology|July 7, 2025
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysisJames B Yu, Michael R Folkert, Ryoko Sato, et al.
Cureus|February 25, 2025
Timing and Patterns of Potentially Salvageable Recurrences Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer Assessed by Preferential Amino Acid UptakeTim Kearney, Lauren Nagel, Matthew Bourne, et al.
Plos One|February 29, 2020
Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weightCarrie McMahon, James L Trevaskis, Christoph Carter, et al.
Oncotarget|June 22, 2018
TNFAIP8 promotes prostate cancer cell survival by inducing autophagySuryakant Niture, Malathi Ramalinga, Habib Kedir, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Cureus|July 26, 2024
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation PlanningLauren Ching, Matthew Bourne, Tim Kearney, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2020
Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomyStephanie Yoon, Minsong Cao, Nima Aghdam, et al.
Scientific Reports|July 28, 2019
Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERNBen Webster, Peter Ivanov, Ben Russell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2020
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI ResistanceRima K Acosta, Madeleine Willkom, Kristen Andreatta, et al.
Radiation Oncology (London, England)|November 16, 2014
Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3))Einsley Janowski, Leonard N Chen, Joy S Kim, et al.
BMJ Open|October 19, 2021
Buteyko method for people with asthma: a protocol for a systematic review and meta-analysisKarla Morganna Pereira Pinto de Mendonça, Sean Collins, Tácito Zm Santos, et al.
World Journal of Urology|July 7, 2025
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysisJames B Yu, Michael R Folkert, Ryoko Sato, et al.
Cureus|February 25, 2025
Timing and Patterns of Potentially Salvageable Recurrences Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer Assessed by Preferential Amino Acid UptakeTim Kearney, Lauren Nagel, Matthew Bourne, et al.
Plos One|February 29, 2020
Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weightCarrie McMahon, James L Trevaskis, Christoph Carter, et al.
Oncotarget|June 22, 2018
TNFAIP8 promotes prostate cancer cell survival by inducing autophagySuryakant Niture, Malathi Ramalinga, Habib Kedir, et al.
Pageof 14